This inventor holds 1 USPTO granted patent. Top assignee: Treventis Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by Sheila Marie H Jacobo in Protein Folding Disorders
Introduction
Sheila Marie H Jacobo is an accomplished inventor based in Menands, NY (US). She has made significant contributions to the field of biomedical research, particularly in the treatment of protein folding disorders. Her innovative work has the potential to impact the lives of many individuals suffering from neurodegenerative diseases.
Latest Patents
Sheila holds 1 patent for her invention titled "Compounds and methods for treating protein folding disorders." This invention is directed towards developing compounds and methods that can effectively treat various neurodegenerative diseases, including Alzheimer's disease, tauopathy, cerebral amyloid angiopathy, Lewy body disease, dementia, Huntington's disease, and prion-based spongiform encephalopathy. The invention also provides pharmaceutical compositions aimed at inhibiting the aggregation of tau protein, Aβ protein, or α-synuclein protein.
Career Highlights
Sheila is currently associated with Treventis Corporation, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing fight against neurodegenerative diseases, and her innovative approaches are paving the way for new therapeutic options.
Collaborations
Sheila collaborates with notable colleagues, including Michael D Carter and Donald F Weaver. Their combined expertise enhances the research efforts at Treventis Corporation and contributes to the advancement of treatments for complex medical conditions.
Conclusion
Sheila Marie H Jacobo's contributions to the field of protein folding disorders exemplify the impact of innovation in medicine. Her dedication to developing effective treatments for neurodegenerative diseases is commendable and highlights the importance of continued research in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile